ZTSHealthcare · Drug Manufacturers - Specialty & Generic

Zoetis Inc.

DeepValues Research covers Zoetis (ZTS) with 1 research report since May 13, 2026. The latest Deep Value Intelligence report (May 13, 2026) ends with a Neutral stance (3.78/5). Sector: Healthcare · Drug Manufacturers - Specialty & Generic.

Latest stanceNeutral3.78May 13, 2026

Reports1since May 13, 2026

Latest reportMay 13, 2026EN

Research timeline

May 13, 2026

Deep Value Intelligence
Zoetis Inc. (ZTS) Deep Value Intelligence Report
Neutral (3.78/5) on Zoetis (ZTS), May 13, 2026. Price $74. - Zoetis still looks like a high-quality business: 71.8% gross margin, 26.6% ROIC, strong…

Neutral3.78EN53 min

Compare with other Healthcare companies

All Healthcare stocks

Company	Industry	Latest stance	Price · value	Date	Reports
ZTSZoetis	Drug Manufacturers - Specialty & Generic	Neutral3.78	$74	2026-05-13	1
JNJJohnson & Johnson	Drug Manufacturers - General	Neutral3.08	$264 · $184	2026-10-13	3
GRDN	Medical Care Facilities	Bearish3.16	$40 · $14	2026-10-12	1
ALLOAllogene Therapeutics	Biotechnology	Bearish3.10	$1	2026-10-07	1
MRNA	Biotechnology	Neutral3.01	$199 · $448	2026-09-27	1
CRSPCRISPR Therapeutics	Biotechnology	Neutral2.30	$56	2026-09-23	1
INSMInsmed	Biotechnology	Bearish2.52	$118	2026-09-23	1
ABTAbbott Laboratories	Medical Devices	Neutral3.05	$103 · $59	2026-09-15	9
ABBVAbbVie	Drug Manufacturers - General	Bullish2.35	$257 · $151	2026-09-13	11

Charts from the latest report

Open report

Current vs Historical Average Comparison

10-Year Financial Summary Table (Best-Effort)